In breast cancer cell lines, almost one third (55/167) of miRNA promoters were targets for aberrant methylation (epigenetic repression).
Nas liñas celulares de cancro de mama, case un terzo (55/167) dos promotores de miARN eran dianas para a metilación anormal (represión epixenética).